PF-5212374
(Synonyms:(TRU-015))
目录号 : KM35666
CAS No. : 1169717-01-4
纯度 : 97%
PF-5212374 (TRU-015) 是 CHO 表达的人源抗体,靶向 CD20/MS4A1。PF-5212374 具有强效的直接信号传导和抗体依赖的细胞毒性。PF-5212374 补体依赖的细胞毒性比 Rituximab 低。PF-5212374 具有抗肿瘤的活性。PF-5212374 可用于淋巴瘤等肿瘤和炎症性疾病的研究。
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
PF-5212374 (TRU-015) is a humanized antibody expressed in CHO, targeting CD20/MS4A1. PF-5212374 exhibits potent direct signaling and antibody-dependent cellular cytotoxicity, with complement-mediated cytotoxicity lower than that of Rituximab . PF-5212374 has antitumor activity and can be used in the research of tumors such as lymphoma and inflammatory diseases.
|
| CAS号 |
1169717-01-4
|
| 运输条件 |
Shipping with dry ice.
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|